Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07558733 |
| Title | Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Faeth Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| START Los Angeles | RECRUITING | Los Angeles | California | 90025 | United States | Details |
| Oncology Associates of Oregon | RECRUITING | Springfield | Oregon | 97477 | United States | Details |
| SCRI Oncology Partners | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |